SYRE Overview
Upcoming Projects (SYRE)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (SYRE)
-
A Third Look: Discussing the potential of Tulisokibart (MK-7240) and SPY001, an investigational anti-TL1A monoclonal antibody being developed for the management of IBD.
Tickers: MRK, SYRE
Executed On: Dec 19, 2024 at 03:30 PM EST -
A Second Look: Discussing the potential of Tulisokibart (MK-7240) and SPY001, an investigational anti-TL1A monoclonal antibody being developed for the management of IBD.
Tickers: MRK, SYRE
Executed On: Nov 20, 2024 at 04:00 PM EST -
Discussing the potential of Tulisokibart (MK-7240) and SPY001, an investigational anti-TL1A monoclonal antibody being developed for the management of IBD.
Tickers: MRK, SYRE
Executed On: Nov 19, 2024 at 06:05 PM EST
Upcoming & Overdue Catalysts (SYRE)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (SYRE)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
